A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma–associated herpesvirus la
Author: ["Masahiro Fujimuro","Frederick Y. Wu","Colette apRhys","Henry Kajumbula","David B. Young","Gary S. Hayward","S. Diane Hayward"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
The Kaposi's sarcoma–associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) is expressed in all KSHV-associated tumors, including Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL). We found that β-catenin is overexpressed in both PEL cells and KS tissue. Introduction of anti-LANA small interfering RNA (siRNA) into PEL cells eliminated β-catenin accumulation; LANA itself upregulated expression of β-catenin in transfected cells. LANA stabilizes β-catenin by binding to the negative regulator GSK-3β, causing a cell cycle–dependent nuclear accumulation of GSK-3β. The LANA C terminus contains sequences similar to the GSK-3β-binding domain of Axin. Disruption of this region resulted in a mutant LANA that failed to re-localize GSK-3β or stabilize β-catenin. The importance of this pathway to KSHV-driven cell proliferation was highlighted by the observation that LANA, but not mutant LANA, stimulates entry into S phase. Redistribution of GSK-3β can therefore be a source of β-catenin dysregulation in human cancers.
Cite this article
Fujimuro, M., Wu, F., apRhys, C. et al. A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma–associated herpesvirus latency. Nat Med 9, 300–306 (2003). https://doi.org/10.1038/nm829
